ABOUT US
CONTACT US
FAQ
PRIVACY POLICY
REFUND AND CANCELLATION
BLOGS
COMPANIES
REPORTS
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Meningococcal Vaccination Market Research Report 2025
Published Date: July 2025
|
Report Code: QYRE-Auto-17R8482
Home | Market Reports | Health| Health Conditions| Infectious Diseases
Global Meningococcal Vaccination Market Insights Forecast to 2028
BUY CHAPTERS

Global Meningococcal Vaccination Market Research Report 2025

Code: QYRE-Auto-17R8482
Report
July 2025
Pages:78
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES
FEATURED COMPANIES
GlaxoSmithKline PLC
JN-International Medical
Novartis International
Sanofi
Pfizer Inc
Baxter International
Biomed
Serum Institute of India

Meningococcal Vaccination Market Size

The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years.

Meningococcal Vaccination Market

Meningococcal Vaccination Market

The global market for Meningococcal Vaccination was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Meningococcal Vaccination, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Meningococcal Vaccination.
The Meningococcal Vaccination market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Meningococcal Vaccination market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Meningococcal Vaccination manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Scope of Meningococcal Vaccination Market Report

Report Metric Details
Report Name Meningococcal Vaccination Market
CAGR 5%
Segment by Type
  • Polysaccharide
  • Conjugate
  • Combination
Segment by Application
Consumption by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia)
  • Asia-Pacific (China, Japan, South Korea, Taiwan)
  • Southeast Asia (India)
  • Latin America (Mexico, Brazil)
By Company GlaxoSmithKline, JN-International Medical, Novartis International, Sanofi, Pfizer, Baxter International, Biomed, Serum Institute of India
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Core Chapters

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Detailed analysis of Meningococcal Vaccination manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 3: Sales, revenue of Meningococcal Vaccination in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
  • Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
  • Chapter 9: The main points and conclusions of the report. 

FAQ for this report

Who are the main players in the Meningococcal Vaccination Market report?

Ans: The main players in the Meningococcal Vaccination Market are GlaxoSmithKline, JN-International Medical, Novartis International, Sanofi, Pfizer, Baxter International, Biomed, Serum Institute of India

What are the Application segmentation covered in the Meningococcal Vaccination Market report?

Ans: The Applications covered in the Meningococcal Vaccination Market report are Pneumonia, Meningitis, Bacteremia, Others

What are the Type segmentation covered in the Meningococcal Vaccination Market report?

Ans: The Types covered in the Meningococcal Vaccination Market report are Polysaccharide, Conjugate, Combination

Recommended Reports

Meningococcal & Conjugate Vaccines

Pediatric & Preventive Vaccines

Vaccine Delivery & Monitoring

1 Meningococcal Vaccination Market Overview
1.1 Product Definition
1.2 Meningococcal Vaccination by Type
1.2.1 Global Meningococcal Vaccination Market Value Comparison by Type (2024 VS 2031)
1.2.2 Polysaccharide
1.2.3 Conjugate
1.2.4 Combination
1.3 Meningococcal Vaccination by Application
1.3.1 Global Meningococcal Vaccination Market Value by Application (2024 VS 2031)
1.3.2 Pneumonia
1.3.3 Meningitis
1.3.4 Bacteremia
1.3.5 Others
1.4 Global Meningococcal Vaccination Market Size Estimates and Forecasts
1.4.1 Global Meningococcal Vaccination Revenue 2020-2031
1.4.2 Global Meningococcal Vaccination Sales 2020-2031
1.4.3 Global Meningococcal Vaccination Market Average Price (2020-2031)
1.5 Assumptions and Limitations
2 Meningococcal Vaccination Market Competition by Manufacturers
2.1 Global Meningococcal Vaccination Sales Market Share by Manufacturers (2020-2025)
2.2 Global Meningococcal Vaccination Revenue Market Share by Manufacturers (2020-2025)
2.3 Global Meningococcal Vaccination Average Price by Manufacturers (2020-2025)
2.4 Global Key Players of Meningococcal Vaccination, Industry Ranking, 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Meningococcal Vaccination, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Meningococcal Vaccination, Product Type & Application
2.7 Global Key Manufacturers of Meningococcal Vaccination, Date of Enter into This Industry
2.8 Global Meningococcal Vaccination Market Competitive Situation and Trends
2.8.1 Global Meningococcal Vaccination Market Concentration Rate
2.8.2 The Global 5 and 10 Largest Meningococcal Vaccination Players Market Share by Revenue
2.8.3 Global Meningococcal Vaccination Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Meningococcal Vaccination Market Scenario by Region
3.1 Global Meningococcal Vaccination Market Size by Region: 2020 Versus 2024 Versus 2031
3.2 Global Meningococcal Vaccination Sales by Region: 2020-2031
3.2.1 Global Meningococcal Vaccination Sales by Region: 2020-2025
3.2.2 Global Meningococcal Vaccination Sales by Region: 2026-2031
3.3 Global Meningococcal Vaccination Revenue by Region: 2020-2031
3.3.1 Global Meningococcal Vaccination Revenue by Region: 2020-2025
3.3.2 Global Meningococcal Vaccination Revenue by Region: 2026-2031
3.4 North America Meningococcal Vaccination Market Facts & Figures by Country
3.4.1 North America Meningococcal Vaccination Market Size by Country: 2020 VS 2024 VS 2031
3.4.2 North America Meningococcal Vaccination Sales by Country (2020-2031)
3.4.3 North America Meningococcal Vaccination Revenue by Country (2020-2031)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Meningococcal Vaccination Market Facts & Figures by Country
3.5.1 Europe Meningococcal Vaccination Market Size by Country: 2020 VS 2024 VS 2031
3.5.2 Europe Meningococcal Vaccination Sales by Country (2020-2031)
3.5.3 Europe Meningococcal Vaccination Revenue by Country (2020-2031)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Meningococcal Vaccination Market Facts & Figures by Region
3.6.1 Asia Pacific Meningococcal Vaccination Market Size by Region: 2020 VS 2024 VS 2031
3.6.2 Asia Pacific Meningococcal Vaccination Sales by Region (2020-2031)
3.6.3 Asia Pacific Meningococcal Vaccination Revenue by Region (2020-2031)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.6.13 Philippines
3.7 Latin America Meningococcal Vaccination Market Facts & Figures by Country
3.7.1 Latin America Meningococcal Vaccination Market Size by Country: 2020 VS 2024 VS 2031
3.7.2 Latin America Meningococcal Vaccination Sales by Country (2020-2031)
3.7.3 Latin America Meningococcal Vaccination Revenue by Country (2020-2031)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Meningococcal Vaccination Market Facts & Figures by Country
3.8.1 Middle East and Africa Meningococcal Vaccination Market Size by Country: 2020 VS 2024 VS 2031
3.8.2 Middle East and Africa Meningococcal Vaccination Sales by Country (2020-2031)
3.8.3 Middle East and Africa Meningococcal Vaccination Revenue by Country (2020-2031)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Meningococcal Vaccination Sales by Type (2020-2031)
4.1.1 Global Meningococcal Vaccination Sales by Type (2020-2025)
4.1.2 Global Meningococcal Vaccination Sales by Type (2026-2031)
4.1.3 Global Meningococcal Vaccination Sales Market Share by Type (2020-2031)
4.2 Global Meningococcal Vaccination Revenue by Type (2020-2031)
4.2.1 Global Meningococcal Vaccination Revenue by Type (2020-2025)
4.2.2 Global Meningococcal Vaccination Revenue by Type (2026-2031)
4.2.3 Global Meningococcal Vaccination Revenue Market Share by Type (2020-2031)
4.3 Global Meningococcal Vaccination Price by Type (2020-2031)
5 Segment by Application
5.1 Global Meningococcal Vaccination Sales by Application (2020-2031)
5.1.1 Global Meningococcal Vaccination Sales by Application (2020-2025)
5.1.2 Global Meningococcal Vaccination Sales by Application (2026-2031)
5.1.3 Global Meningococcal Vaccination Sales Market Share by Application (2020-2031)
5.2 Global Meningococcal Vaccination Revenue by Application (2020-2031)
5.2.1 Global Meningococcal Vaccination Revenue by Application (2020-2025)
5.2.2 Global Meningococcal Vaccination Revenue by Application (2026-2031)
5.2.3 Global Meningococcal Vaccination Revenue Market Share by Application (2020-2031)
5.3 Global Meningococcal Vaccination Price by Application (2020-2031)
6 Key Companies Profiled
6.1 GlaxoSmithKline
6.1.1 GlaxoSmithKline Company Information
6.1.2 GlaxoSmithKline Description and Business Overview
6.1.3 GlaxoSmithKline Meningococcal Vaccination Sales, Revenue and Gross Margin (2020-2025)
6.1.4 GlaxoSmithKline Meningococcal Vaccination Product Portfolio
6.1.5 GlaxoSmithKline Recent Developments/Updates
6.2 JN-International Medical
6.2.1 JN-International Medical Company Information
6.2.2 JN-International Medical Description and Business Overview
6.2.3 JN-International Medical Meningococcal Vaccination Sales, Revenue and Gross Margin (2020-2025)
6.2.4 JN-International Medical Meningococcal Vaccination Product Portfolio
6.2.5 JN-International Medical Recent Developments/Updates
6.3 Novartis International
6.3.1 Novartis International Company Information
6.3.2 Novartis International Description and Business Overview
6.3.3 Novartis International Meningococcal Vaccination Sales, Revenue and Gross Margin (2020-2025)
6.3.4 Novartis International Meningococcal Vaccination Product Portfolio
6.3.5 Novartis International Recent Developments/Updates
6.4 Sanofi
6.4.1 Sanofi Company Information
6.4.2 Sanofi Description and Business Overview
6.4.3 Sanofi Meningococcal Vaccination Sales, Revenue and Gross Margin (2020-2025)
6.4.4 Sanofi Meningococcal Vaccination Product Portfolio
6.4.5 Sanofi Recent Developments/Updates
6.5 Pfizer
6.5.1 Pfizer Company Information
6.5.2 Pfizer Description and Business Overview
6.5.3 Pfizer Meningococcal Vaccination Sales, Revenue and Gross Margin (2020-2025)
6.5.4 Pfizer Meningococcal Vaccination Product Portfolio
6.5.5 Pfizer Recent Developments/Updates
6.6 Baxter International
6.6.1 Baxter International Company Information
6.6.2 Baxter International Description and Business Overview
6.6.3 Baxter International Meningococcal Vaccination Sales, Revenue and Gross Margin (2020-2025)
6.6.4 Baxter International Meningococcal Vaccination Product Portfolio
6.6.5 Baxter International Recent Developments/Updates
6.7 Biomed
6.7.1 Biomed Company Information
6.7.2 Biomed Description and Business Overview
6.7.3 Biomed Meningococcal Vaccination Sales, Revenue and Gross Margin (2020-2025)
6.7.4 Biomed Meningococcal Vaccination Product Portfolio
6.7.5 Biomed Recent Developments/Updates
6.8 Serum Institute of India
6.8.1 Serum Institute of India Company Information
6.8.2 Serum Institute of India Description and Business Overview
6.8.3 Serum Institute of India Meningococcal Vaccination Sales, Revenue and Gross Margin (2020-2025)
6.8.4 Serum Institute of India Meningococcal Vaccination Product Portfolio
6.8.5 Serum Institute of India Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Meningococcal Vaccination Industry Chain Analysis
7.2 Meningococcal Vaccination Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Meningococcal Vaccination Production Mode & Process Analysis
7.4 Meningococcal Vaccination Sales and Marketing
7.4.1 Meningococcal Vaccination Sales Channels
7.4.2 Meningococcal Vaccination Distributors
7.5 Meningococcal Vaccination Customer Analysis
8 Meningococcal Vaccination Market Dynamics
8.1 Meningococcal Vaccination Industry Trends
8.2 Meningococcal Vaccination Market Drivers
8.3 Meningococcal Vaccination Market Challenges
8.4 Meningococcal Vaccination Market Restraints
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
FEATURED COMPANIES
GlaxoSmithKline PLC
JN-International Medical
Novartis International
Sanofi
Pfizer Inc
Baxter International
Biomed
Serum Institute of India
List of Tables
 Table 1. Global Meningococcal Vaccination Market Value Comparison by Type (2024 VS 2031) & (US$ Million)
 Table 2. Global Meningococcal Vaccination Market Value by Application (2024 VS 2031) & (US$ Million)
 Table 3. Global Meningococcal Vaccination Market Competitive Situation by Manufacturers in 2024
 Table 4. Global Meningococcal Vaccination Sales (K Units) of Key Manufacturers (2020-2025)
 Table 5. Global Meningococcal Vaccination Sales Market Share by Manufacturers (2020-2025)
 Table 6. Global Meningococcal Vaccination Revenue (US$ Million) by Manufacturers (2020-2025)
 Table 7. Global Meningococcal Vaccination Revenue Share by Manufacturers (2020-2025)
 Table 8. Global Market Meningococcal Vaccination Average Price (US$/Unit) of Key Manufacturers (2020-2025)
 Table 9. Global Key Players of Meningococcal Vaccination, Industry Ranking, 2022 VS 2023 VS 2024
 Table 10. Global Key Manufacturers of Meningococcal Vaccination, Manufacturing Sites & Headquarters
 Table 11. Global Key Manufacturers of Meningococcal Vaccination, Product Type & Application
 Table 12. Global Key Manufacturers of Meningococcal Vaccination, Date of Enter into This Industry
 Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
 Table 14. Global Meningococcal Vaccination by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Meningococcal Vaccination as of 2024)
 Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
 Table 16. Global Meningococcal Vaccination Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 17. Global Meningococcal Vaccination Sales by Region (2020-2025) & (K Units)
 Table 18. Global Meningococcal Vaccination Sales Market Share by Region (2020-2025)
 Table 19. Global Meningococcal Vaccination Sales by Region (2026-2031) & (K Units)
 Table 20. Global Meningococcal Vaccination Sales Market Share by Region (2026-2031)
 Table 21. Global Meningococcal Vaccination Revenue by Region (2020-2025) & (US$ Million)
 Table 22. Global Meningococcal Vaccination Revenue Market Share by Region (2020-2025)
 Table 23. Global Meningococcal Vaccination Revenue by Region (2026-2031) & (US$ Million)
 Table 24. Global Meningococcal Vaccination Revenue Market Share by Region (2026-2031)
 Table 25. North America Meningococcal Vaccination Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 26. North America Meningococcal Vaccination Sales by Country (2020-2025) & (K Units)
 Table 27. North America Meningococcal Vaccination Sales by Country (2026-2031) & (K Units)
 Table 28. North America Meningococcal Vaccination Revenue by Country (2020-2025) & (US$ Million)
 Table 29. North America Meningococcal Vaccination Revenue by Country (2026-2031) & (US$ Million)
 Table 30. Europe Meningococcal Vaccination Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 31. Europe Meningococcal Vaccination Sales by Country (2020-2025) & (K Units)
 Table 32. Europe Meningococcal Vaccination Sales by Country (2026-2031) & (K Units)
 Table 33. Europe Meningococcal Vaccination Revenue by Country (2020-2025) & (US$ Million)
 Table 34. Europe Meningococcal Vaccination Revenue by Country (2026-2031) & (US$ Million)
 Table 35. Asia Pacific Meningococcal Vaccination Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Table 36. Asia Pacific Meningococcal Vaccination Sales by Region (2020-2025) & (K Units)
 Table 37. Asia Pacific Meningococcal Vaccination Sales by Region (2026-2031) & (K Units)
 Table 38. Asia Pacific Meningococcal Vaccination Revenue by Region (2020-2025) & (US$ Million)
 Table 39. Asia Pacific Meningococcal Vaccination Revenue by Region (2026-2031) & (US$ Million)
 Table 40. Latin America Meningococcal Vaccination Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 41. Latin America Meningococcal Vaccination Sales by Country (2020-2025) & (K Units)
 Table 42. Latin America Meningococcal Vaccination Sales by Country (2026-2031) & (K Units)
 Table 43. Latin America Meningococcal Vaccination Revenue by Country (2020-2025) & (US$ Million)
 Table 44. Latin America Meningococcal Vaccination Revenue by Country (2026-2031) & (US$ Million)
 Table 45. Middle East and Africa Meningococcal Vaccination Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 46. Middle East and Africa Meningococcal Vaccination Sales by Country (2020-2025) & (K Units)
 Table 47. Middle East and Africa Meningococcal Vaccination Sales by Country (2026-2031) & (K Units)
 Table 48. Middle East and Africa Meningococcal Vaccination Revenue by Country (2020-2025) & (US$ Million)
 Table 49. Middle East and Africa Meningococcal Vaccination Revenue by Country (2026-2031) & (US$ Million)
 Table 50. Global Meningococcal Vaccination Sales (K Units) by Type (2020-2025)
 Table 51. Global Meningococcal Vaccination Sales (K Units) by Type (2026-2031)
 Table 52. Global Meningococcal Vaccination Sales Market Share by Type (2020-2025)
 Table 53. Global Meningococcal Vaccination Sales Market Share by Type (2026-2031)
 Table 54. Global Meningococcal Vaccination Revenue (US$ Million) by Type (2020-2025)
 Table 55. Global Meningococcal Vaccination Revenue (US$ Million) by Type (2026-2031)
 Table 56. Global Meningococcal Vaccination Revenue Market Share by Type (2020-2025)
 Table 57. Global Meningococcal Vaccination Revenue Market Share by Type (2026-2031)
 Table 58. Global Meningococcal Vaccination Price (US$/Unit) by Type (2020-2025)
 Table 59. Global Meningococcal Vaccination Price (US$/Unit) by Type (2026-2031)
 Table 60. Global Meningococcal Vaccination Sales (K Units) by Application (2020-2025)
 Table 61. Global Meningococcal Vaccination Sales (K Units) by Application (2026-2031)
 Table 62. Global Meningococcal Vaccination Sales Market Share by Application (2020-2025)
 Table 63. Global Meningococcal Vaccination Sales Market Share by Application (2026-2031)
 Table 64. Global Meningococcal Vaccination Revenue (US$ Million) by Application (2020-2025)
 Table 65. Global Meningococcal Vaccination Revenue (US$ Million) by Application (2026-2031)
 Table 66. Global Meningococcal Vaccination Revenue Market Share by Application (2020-2025)
 Table 67. Global Meningococcal Vaccination Revenue Market Share by Application (2026-2031)
 Table 68. Global Meningococcal Vaccination Price (US$/Unit) by Application (2020-2025)
 Table 69. Global Meningococcal Vaccination Price (US$/Unit) by Application (2026-2031)
 Table 70. GlaxoSmithKline Company Information
 Table 71. GlaxoSmithKline Description and Business Overview
 Table 72. GlaxoSmithKline Meningococcal Vaccination Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 73. GlaxoSmithKline Meningococcal Vaccination Product
 Table 74. GlaxoSmithKline Recent Developments/Updates
 Table 75. JN-International Medical Company Information
 Table 76. JN-International Medical Description and Business Overview
 Table 77. JN-International Medical Meningococcal Vaccination Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 78. JN-International Medical Meningococcal Vaccination Product
 Table 79. JN-International Medical Recent Developments/Updates
 Table 80. Novartis International Company Information
 Table 81. Novartis International Description and Business Overview
 Table 82. Novartis International Meningococcal Vaccination Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 83. Novartis International Meningococcal Vaccination Product
 Table 84. Novartis International Recent Developments/Updates
 Table 85. Sanofi Company Information
 Table 86. Sanofi Description and Business Overview
 Table 87. Sanofi Meningococcal Vaccination Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 88. Sanofi Meningococcal Vaccination Product
 Table 89. Sanofi Recent Developments/Updates
 Table 90. Pfizer Company Information
 Table 91. Pfizer Description and Business Overview
 Table 92. Pfizer Meningococcal Vaccination Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 93. Pfizer Meningococcal Vaccination Product
 Table 94. Pfizer Recent Developments/Updates
 Table 95. Baxter International Company Information
 Table 96. Baxter International Description and Business Overview
 Table 97. Baxter International Meningococcal Vaccination Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 98. Baxter International Meningococcal Vaccination Product
 Table 99. Baxter International Recent Developments/Updates
 Table 100. Biomed Company Information
 Table 101. Biomed Description and Business Overview
 Table 102. Biomed Meningococcal Vaccination Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 103. Biomed Meningococcal Vaccination Product
 Table 104. Biomed Recent Developments/Updates
 Table 105. Serum Institute of India Company Information
 Table 106. Serum Institute of India Description and Business Overview
 Table 107. Serum Institute of India Meningococcal Vaccination Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 108. Serum Institute of India Meningococcal Vaccination Product
 Table 109. Serum Institute of India Recent Developments/Updates
 Table 110. Key Raw Materials Lists
 Table 111. Raw Materials Key Suppliers Lists
 Table 112. Meningococcal Vaccination Distributors List
 Table 113. Meningococcal Vaccination Customers List
 Table 114. Meningococcal Vaccination Market Trends
 Table 115. Meningococcal Vaccination Market Drivers
 Table 116. Meningococcal Vaccination Market Challenges
 Table 117. Meningococcal Vaccination Market Restraints
 Table 118. Research Programs/Design for This Report
 Table 119. Key Data Information from Secondary Sources
 Table 120. Key Data Information from Primary Sources
 Table 121. Authors List of This Report


List of Figures
 Figure 1. Product Picture of Meningococcal Vaccination
 Figure 2. Global Meningococcal Vaccination Market Value Comparison by Type (2020-2031) & (US$ Million)
 Figure 3. Global Meningococcal Vaccination Market Share by Type: 2024 & 2031
 Figure 4. Polysaccharide Product Picture
 Figure 5. Conjugate Product Picture
 Figure 6. Combination Product Picture
 Figure 7. Global Meningococcal Vaccination Market Value by Application (2020-2031) & (US$ Million)
 Figure 8. Global Meningococcal Vaccination Market Share by Application: 2024 & 2031
 Figure 9. Pneumonia
 Figure 10. Meningitis
 Figure 11. Bacteremia
 Figure 12. Others
 Figure 13. Global Meningococcal Vaccination Revenue, (US$ Million), 2020 VS 2024 VS 2031
 Figure 14. Global Meningococcal Vaccination Market Size (2020-2031) & (US$ Million)
 Figure 15. Global Meningococcal Vaccination Sales (2020-2031) & (K Units)
 Figure 16. Global Meningococcal Vaccination Average Price (US$/Unit) & (2020-2031)
 Figure 17. Meningococcal Vaccination Report Years Considered
 Figure 18. Meningococcal Vaccination Sales Share by Manufacturers in 2024
 Figure 19. Global Meningococcal Vaccination Revenue Share by Manufacturers in 2024
 Figure 20. Global 5 and 10 Largest Meningococcal Vaccination Players: Market Share by Revenue in Meningococcal Vaccination in 2024
 Figure 21. Meningococcal Vaccination Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
 Figure 22. Global Meningococcal Vaccination Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Figure 23. North America Meningococcal Vaccination Sales Market Share by Country (2020-2031)
 Figure 24. North America Meningococcal Vaccination Revenue Market Share by Country (2020-2031)
 Figure 25. U.S. Meningococcal Vaccination Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 26. Canada Meningococcal Vaccination Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 27. Europe Meningococcal Vaccination Sales Market Share by Country (2020-2031)
 Figure 28. Europe Meningococcal Vaccination Revenue Market Share by Country (2020-2031)
 Figure 29. Germany Meningococcal Vaccination Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 30. France Meningococcal Vaccination Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 31. U.K. Meningococcal Vaccination Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 32. Italy Meningococcal Vaccination Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 33. Russia Meningococcal Vaccination Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 34. Asia Pacific Meningococcal Vaccination Sales Market Share by Region (2020-2031)
 Figure 35. Asia Pacific Meningococcal Vaccination Revenue Market Share by Region (2020-2031)
 Figure 36. China Meningococcal Vaccination Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 37. Japan Meningococcal Vaccination Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 38. South Korea Meningococcal Vaccination Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 39. India Meningococcal Vaccination Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 40. Australia Meningococcal Vaccination Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 41. Taiwan Meningococcal Vaccination Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 42. Indonesia Meningococcal Vaccination Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 43. Thailand Meningococcal Vaccination Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 44. Malaysia Meningococcal Vaccination Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 45. Philippines Meningococcal Vaccination Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 46. Latin America Meningococcal Vaccination Sales Market Share by Country (2020-2031)
 Figure 47. Latin America Meningococcal Vaccination Revenue Market Share by Country (2020-2031)
 Figure 48. Mexico Meningococcal Vaccination Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 49. Brazil Meningococcal Vaccination Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 50. Argentina Meningococcal Vaccination Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 51. Middle East and Africa Meningococcal Vaccination Sales Market Share by Country (2020-2031)
 Figure 52. Middle East and Africa Meningococcal Vaccination Revenue Market Share by Country (2020-2031)
 Figure 53. Turkey Meningococcal Vaccination Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 54. Saudi Arabia Meningococcal Vaccination Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 55. UAE Meningococcal Vaccination Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 56. Global Sales Market Share of Meningococcal Vaccination by Type (2020-2031)
 Figure 57. Global Revenue Market Share of Meningococcal Vaccination by Type (2020-2031)
 Figure 58. Global Meningococcal Vaccination Price (US$/Unit) by Type (2020-2031)
 Figure 59. Global Sales Market Share of Meningococcal Vaccination by Application (2020-2031)
 Figure 60. Global Revenue Market Share of Meningococcal Vaccination by Application (2020-2031)
 Figure 61. Global Meningococcal Vaccination Price (US$/Unit) by Application (2020-2031)
 Figure 62. Meningococcal Vaccination Value Chain
 Figure 63. Channels of Distribution (Direct Vs Distribution)
 Figure 64. Bottom-up and Top-down Approaches for This Report
 Figure 65. Data Triangulation
 Figure 66. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)
INQUIRE FOR DISCOUNT

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Seventh Sense AI

SIMILAR REPORTS

Global Meningitis Vaccine Market Research Report 2025
Global Prevent Meningitis Vaccine Market Research Report 2025
Global Group ACYW135 Meningococcal Polysaccharide Vaccine Market Research Report 2025
Global Neisseria meningitidis Infections Drug Market Research Report 2024
23 valent Pneumococcal Vaccine Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Human Bacterial Vaccine Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Meningococcal Disease Vaccine Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Streptococcus Pneumoniae Vaccine Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global GP Vaccination Market Research Report 2025
Prostate Cancer Vaccines Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Vaccine Ampoules Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Therapeutic BCG Vaccines Market Insights Forecast to 2030
Influenza A Vaccine Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Pneumococcal Conjugate Vaccine PCV Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Vaccine Administration Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Preventable Vaccines Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Vaccines Delivery Devices Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Vaccines Packaging Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Pediatric Vaccines Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Vaccination Cart Market Research Report 2024
Call
Buy Now
REQUEST FREE SAMPLE REPORT
Support Contacts
U.S. (TOLL FREE)
+1 (425) 388-2538
THE COMPANY
OUR PRODUCTS
CUSTOMER SUPPORT
POLICES
THE COMPANY
CUSTOMER SUPPORT
OUR PRODUCTS
POLICES
Copyright © 2018 Valuates.com. All Rights Reserved.
Sitemap - Privacy Policy - Terms & Conditions